American Heart Journal
Volume 155, Issue 2 , Pages 310-315 , February 2008

Atrial fibrillation and obesity—results of a meta-analysis

  • Nikolas Wanahita, MD, MHA

      Affiliations

    • Division of Cardiology, Beth Israel Medical Center, New York, NY
    • ,
  • Franz H. Messerli, MD

      Affiliations

    • Division of Cardiology, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY
    • Corresponding Author InformationReprint requests: Franz H. Messerli, MD, FACC, FACP, Hypertension Program, Division of Cardiology, St. Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, 1000 10th Avenue, Suite 3B-30, New York, NY 10019.
    • ,
  • Sripal Bangalore, MD, MHA

      Affiliations

    • Division of Cardiology, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY
    • ,
  • Apoor S. Gami, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Virend K. Somers, MD, PhD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN
    • ,
  • Jonathan S. Steinberg, MD

      Affiliations

    • Division of Cardiology, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY

Received 3 August 2007 ,Accepted 1 October 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Messerli served as an ad hoc consultant/speaker for the following organizations: Abbott, GSK, Novartis, Pfizer, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Forest, Sankyo, and Sanofi. Dr Somers is supported by grants HL 73211, HL 65176, and MO1-RR00585 from the National institutes of Health (Bethesda, MD). He serves as a consultant for Respironics, Cardiac Concepts, ResMed, and Sepracor.

 This work was presented in part at the 2007 Annual Scientific Session of the American College of Cardiology, New Orleans, LA.

PII: S0002-8703(07)00783-1

doi: 10.1016/j.ahj.2007.10.004

American Heart Journal
Volume 155, Issue 2 , Pages 310-315 , February 2008

Article Tools

* Image Usage & Resolution